Chlamydia Screening, HEDIS and Managed Care
Screening for Chlamydia trachomatis, the most common bacterial sexually transmitted disease in the U.S., is included as a HEDIS (Health Plan Employer Data and Information Set) measure since 2000. This HEDIS indicator measures the proportion of sexually active females between the ages of 15 and 24 who were screened for chlamydial infection annually.
- Chlamydia Screening Percentages Reported by Commercial and Medicaid Plans by State and Year - Table and figure of sexually active female enrollees aged 16-24 years who were screened for chlamydia
- Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. - abstract of research published in Sexually Transmitted Diseases February 2013
- 2015 STD Treatment Guidelines - Chlamydial Infections
The Healthcare Effectiveness Data and Information Set (HEDIS) contains a measure which assesses chlamydia screening coverage of sexually active young women who receive medical care through commercial or Medicaid managed care organizations. Among sexually active women aged 16–24 years in commercial health maintenance organization (HMO) plans, chlamydia screening increased from 23.1% in 2001 to 47.0% in 2014. Among sexually-active women aged 16–24 years covered by Medicaid, screening rates increased from 40.4% in 2001 to 58.0% in 2011, then decreased to 54.6% in 2014.7 Although chlamydia screening has expanded over the past two decades, many women who are at risk are still not being tested—reflecting, in part, the lack of awareness among some health care providers and the limited resources available to support these screenings.
- Page last reviewed: October 29, 2013
- Page last updated: February 6, 2017
- Content source: